Dana-Farber Cancer Institute, affiliated with Harvard University, is retracting six studies and correcting 31 others after a blogger uncovered manipulated scientific images in papers authored by several scientists.
The institute’s president and CEO, Dr. Laurie Glimcher, is under investigation for papers that blogger Sholto David alleges helped build her career.
David wrote, “No doubt Laurie built her career on papers like this one, in Nature Immunology (2003), which includes some impressive contributions to art, but perhaps not to science.”
“In 2012 this epic fail was published, Irene gained ethical approval to aspirate bone marrow from cancer patients and healthy volunteers, but Figure 1 includes three obvious duplications,” he explained.
“Wouldn’t the volunteers be furious after undergoing such an invasive procedure? “Can the data from a paper like this ever be rehabilitated?” he asked.
Conservative activist Christopher Rufo said, “There is an enormous amount of fraud, plagiarism, and falsification in elite academia.”
“What we’re seeing with Claudine Gay and the Harvard teaching hospital is only the beginning. It’s time for Americans to stop subsidizing this madness,” he continued.
Barrett Rollins, Dana-Farber’s research integrity officer and chief science officer emeritus, said, “The presence of image discrepancies in a paper is not evidence of an author’s intent to deceive.”
“That conclusion can only be drawn after a careful, fact-based examination which is an integral part of our response,” he continued.
“Our experience is that errors are often unintentional and do not rise to the level of misconduct,” added the expert.
The investigation occurs amidst Harvard’s former president’s resignation due to plagiarism allegations.
Requests for retractions and corrections have been sent to the journals where the papers were published.
The institute is reviewing over 50 papers by three additional researchers to determine if misconduct occurred.
Read Also:
Iconic Food Chain Closes Due To Crime In Blue State
Donald Trump Jr. Weighs In On VP Pick
